类风湿关节炎与心房颤动诊断后缺血性卒中风险:一项挪威全国注册研究
在挪威全国Cardio-Rheuma注册中,2010至2017年间首次诊断心房颤动的2750例RA患者与158879例非RA患者被纳入分析。RA患者房颤后5年缺血性卒中未调整累积发生率为7.3%(95%CI: 5.9-8.7%),非RA患者为5.0%(95%CI: 4.9-5.2%);性别年龄调整后RA患者卒中HR为1.25(95%CI: 1.05, 1.50),且RA患者接受口服抗凝治疗的可能性更低(调整OR 0.88,95%CI: 0.80, 0.97)。
要点
- 房颤后5年缺血性卒中未调整累积发生率RA患者7.3%(95%CI: 5.9-8.7%)vs 非RA患者5.0%(95%CI: 4.9-5.2%)。
- 性别年龄调整后,RA合并房颤患者缺血性卒中HR为1.25(95%CI: 1.05, 1.50),进一步调整糖尿病、高血压、动脉粥样硬化性心血管疾病及口服抗凝治疗后效应量不变。
- RA患者接受口服抗凝治疗的可能性低于非RA患者(调整OR 0.88,95%CI: 0.80, 0.97)。
核心结论
- 诊断为房颤的RA患者相比非RA房颤患者缺血性卒中风险进一步升高,且接受口服抗凝治疗的可能性更低,强调需改善RA合并房颤患者的卒中预防。
研究设计与样本
- 挪威全国Cardio-Rheuma注册研究,纳入2010至2017年间首次诊断房颤的2750例RA患者和158879例非RA患者,采用竞争风险模型并设3个月延迟进入,评估缺血性卒中的累积发生率和风险率。
主要发现
- 房颤后5年缺血性卒中未调整累积发生率RA患者为7.3%(95%CI: 5.9-8.7%),非RA患者为5.0%(95%CI: 4.9-5.2%)。
- 未调整单变量分析显示,合并RA的房颤患者缺血性卒中HR为1.36(95%CI: 1.13, 1.62),对照为非RA房颤患者。
- 性别和年龄调整后,RA合并房颤患者缺血性卒中HR为1.25(95%CI: 1.05, 1.50),进一步调整糖尿病、高血压、动脉粥样硬化性心血管疾病和口服抗凝治疗后效应量不变。
- RA患者接受口服抗凝治疗的可能性低于非RA患者,调整OR为0.88(95%CI: 0.80, 0.97)。
临床怎么用
- 原文结论强调需要改善RA合并房颤患者的卒中预防,未给出具体推荐条款。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: RA patients have an increased risk for cardiovascular diseases, including atrial fibrillation (AF), but the impact of RA on ischaemic stroke risk in the context of AF remains unknown. We explored whether the risk of ischaemic stroke after diagnosis of AF is further increased among patients with RA compared with non-RA patients. METHODS: In the nationwide Norwegian Cardio-Rheuma Register, we evaluated cumulative incidence and hazard rate of ischaemic stroke after the first AF diagnosis (2750 individuals with RA and 158 879 without RA between 2010 and 2017) by using a competing risk model with a 3-month delayed entry. RESULTS: The 5-year unadjusted cumulative incidence of ischaemic stroke was 7.3% (95% CI: 5.9-8.7%) for patients with RA and 5.0% (95% CI: 4.9-5.2%) for patients without RA. Unadjusted univariate analyses indicated that AF patients with RA had a HR of 1.36 (95% CI: 1.13, 1.62) for ischaemic stroke compared with those without RA. Sex- and age-adjusted HR for ischaemic stroke in RA patients with AF was 1.25 (95% CI: 1.05, 1.50), and the effect size remained unchanged after adjustment for diabetes, hypertension, atherosclerotic cardiovascular disease and oral anticoagulant (OAC) treatment. RA patients were less likely to receive OAC treatment than non-RA patients (adjusted odds ratio 0.88, 95% CI: 0.80, 0.97). CONCLUSION: RA patients diagnosed with AF are at a further increased risk for stroke compared with non-RA patients with AF, and less likely to receive OAC treatment, emphasizing the need to improve stroke prevention in AF patients with RA.
引用
- Kerola AM, Ikdahl E, Engebretsen I, et al. Rheumatoid arthritis and the risk of ischaemic stroke after diagnosis of atrial fibrillation: a Norwegian nationwide register study. Rheumatology (Oxford). 2024. PMID: 39171836. doi:10.1093/rheumatology/keae458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。